Back to search

Poland· PL-100544484

Tacrolimus Dermapharm

A medicinal product containing tacrolimusum, registered in Poland by Sun-Farm Sp. z o.o..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTacrolimus DermapharmATC—REGISTER NO.PL-100544484PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Tacrolimusum
Manufacturer
Sun-Farm Sp. z o.o.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991608446

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tacrolimusum in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tacrolimusum products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Adport, Dailiport
  • Belgium · Adoport, Dailiport
  • Bulgaria · Програф
  • Cyprus · Prograf, Tacrolimus Accord
  • Czechia · Dailiport, Gecrol
  • Germany · Crilomus, Dailiport
  • Denmark · Adport, Dailiport
  • Estonia · Dailiport, Lebsanan
  • Spain · Adoport, Cellmune
  • Finland · Adport, Adport,
  • France · Adoport, Conferoport
  • United Kingdom (Northern Ireland) · Adoport, Ascezo
  • Greece · Atodrit-Dermo, Eczatope Derm
  • Croatia · Atezyrix, Dermitopic
  • Hungary · Prograf, Tacrolimus Stada
  • Ireland · Prograf, Tacrolimus Accord
  • Iceland · Advagraf, Dailiport
  • Italy · Adoport, Carelimus
  • Liechtenstein · Advagraf, Envarsus
  • Lithuania · Dailiport, Lebsanan
  • Luxembourg · Prograft, Sumilor
  • Latvia · Dailiport, Lebsanan
  • Malta · Prograf
  • Netherlands · Adport, Conferoport
  • Norway · Adport, Advagraf
  • Portugal · Adoport, Dermitopic
  • Romania · Prograf, Tacrolimus Sandoz
  • Sweden · Adport, Adport,
  • Slovenia · Adoport, Dailiport
  • Slovakia · Atezyrix, Dailiport

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd594c5e-571e-484a-9ced-53553f72334c
GET /v1/drugs/fd594c5e-571e-484a-9ced-53553f72334c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Maść",
  "source": "urpl",
  "strength": "0,1%",
  "packaging": "05909991608446 ¦ Rpz ¦ 168297\n1 tuba 30 g",
  "substance": null,
  "common_name": "Tacrolimusum",
  "pl_product_id": "100544484",
  "pozwolenie_nr": "318/26",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-08-28"
}

See everything about tacrolimusum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.